Monopar Therapeutics Inc. (MNPR)

SEC filing

Monopar Therapeutics Inc.

MNPR · CIK 1645469

4 · Oct 5, 2026 · Director STARR CHRISTOPHER M sold 8,400 shares at $78.50/share ($659.4K); exercised options for 16.80K shares

Director STARR CHRISTOPHER M sold 8,400 shares at $78.50/share ($659.4K); exercised options for 16.80K shares

FORM 4

xslF345X06/rdgdoc.xmlSEC.gov

Graphics and non-inline formats (not embedded below).